Preoperative findings in non-gynecologic carcinomas metastasizing to the ovaries

Gynecologic and Obstetric Investigation

Volumn 54, Issue 4, 2002, Pages 221-227

  Kikkawa, Fumitaka ^a   Shibata, Kiyosumi ^a   Ino, Kazuhiko ^a   Nomura, Seiji ^a   Kajiyama, Hiroaki ^a   Suzuki, Takahiro ^a   Kawai, Michiyasu ^b   Mizutani, Shigehiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Toyahashi City Hospital   (Japan)

Author keywords

CA125; CEA; Metastasis; Ovarian carcinoma; Prognostic factor; Tumor marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER SURGERY; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; HYSTERECTOMY; INTESTINE CANCER; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURVIVAL RATE;

ABDOMINAL PAIN; BREAST NEOPLASMS; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; INTESTINAL NEOPLASMS; OVARIAN NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; UTERINE HEMORRHAGE;

EID: 0036967045     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068388     Document Type: Article

References (15)

1. Birnkrant A, Sampson J, Sugarbaker PH: Ovarian metastasis from colorectal cancer. Dis Colon Rectum 1986;29:767-771.
2. Taal BG, Hageman PC, Delemarre JF, Bonfrer JM, den Hartog Jager FC: Metastatic ovarian or colonic cancer: A clinical challenge. Eur J Cancer 1992;28:394-399.
3. Kikkawa F, Ishikawa H, Tamakoshi K, Suganuma N. Mizuno K, Kawai M, Arii Y, Tamakoshi A, Kuzuya K, Tomoda Y: Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol 1995;60:227-231.
4. Kikkawa F, Matsuzawa K, Arii Y, Kawai M, Kobayashi I, Nakashima N, Mizutani S: Randomized trial of cisplatin and carboplatin versus cisplatin, vinblastine and bleomycin in ovarian cancer. Gynecol Obstet Invest 2000;50:269-274.
5. Omura G, Blessing JA, Ehrlich CE, Miller A, Yordan E, Creasman WT, Homesley HD: A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Cancer 1986;57:1725-1730.
6. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
7. Wakahara F, Kikkawa F, Nawa A, Tamakoshi K, Tamakoshi K, Ino K, Maeda O, Kawai M, Mizutani S: Diagnostic efficacy of tumor markers, sonography, and intraoperative frozen section for ovarian tumors. Gynecol Obstet Invest 2001;52:147-152.
8. Webb MJ, Decker DG, Mussey E: Cancer metastatic to the ovary. Obstet Gynecol 1974;45:391-396.
9. Mrad K, Morice P, Fabre A, Pautier P, Lhomme C, Duvillard P, Sabourin JC: Krukenberg tumor: A clinico-pathological study of 15 cases. Ann Pathol 2000;20:202-206.
10. Gilliland R, Gill PJ: Incidence and prognosis of Krukenberg tumors in Northern Ireland. Br J Surg 1992;79:1364-1366.
11. Tokuhashi Y, Kikkawa F, Tamakoshi K, Suganuma N, Kuzuya K, Arii Y, Kawai M, Hattori S, Kobayashi I, Furuhashi Y, Nakashima N, Tomoda Y: A randomized trial of cisplatin, vinblastine, and bleomycin versus cyclophosphamide, aclacinomycin, and cisplatin in epithelial ovarian cancer. Oncology 1997;54:281-286.
12. Kikkawa F, Kawai M, Mizuno K, Ishikawa H, Kojima M, Maeda O, Tamakoshi K, Suganuma N, Tomoda Y, Hattori S: Recurrence of epithelial ovarian carcinoma after clinical remission. Gynecol Obstet Invest 1994;38:65-69.
13. Rustin GJ, Nelstrop AE, Crawford M, Ledermann J, Lambert HE, Coleman R, Johnson J, Evans H, Brown S, Oster W: Phase II trial of oral altretamine for relapsed ovarian carcinoma: Evaluation of defining response by serum CA125. J Clin Oncol 1997;15:172-176.
14. Mariani-Costantini R, Muraro R, Ficari F, Valli C, Bei R, Tonelli F, Caramia F, Frati L: Immunohistochemical evidence of immune responses to tumor-associated antigens in lymph nodes of colon carcinoma patients. Cancer 1991;67:2880-2886.
15. Demopoulos RI, Touger L, Dubin N: Secondary ovarian carcinoma: A clinical and pathological evaluation. Int J Gynecol Pathol 1987;6:166-175.